Related Experiment Video
Updated: May 5, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Recent advances in immunotherapy for allergic diseases
David El-Qutob, Gemma Mencia, Enrique Fernandez-Caldas1
1Unit of Allergy, Hospital La Plana, Carretera Vila-Real-Burriana Km. 0.5 Vila-Real (Castellon) 12540, Spain. elqutob@comv.es.
Allergen-specific immunotherapy (SIT) offers a unique approach to treating allergic diseases like allergic rhinitis and asthma by altering the disease course. Recent advancements focus on novel vaccine modifications for various allergens.
Area of Science:
- Immunology and Allergy Research
- Pharmacology and Therapeutics
Background:
- Allergic diseases, including allergic rhinitis (AR) and allergic asthma (AA), represent a significant global health burden.
- Current therapeutic strategies include allergen avoidance, symptomatic medication, and allergen-specific immunotherapy (SIT).
Purpose of the Study:
- To review recent scientific advancements in allergen-specific immunotherapy (SIT).
- To highlight recent patents related to novel immunotherapy approaches for allergic disorders.
Main Methods:
- Comprehensive literature review of recent research and patent filings in the field of allergy immunotherapy.
- Analysis of general and specific modifications applied to allergic vaccines.
Main Results:
- Allergen-specific immunotherapy (SIT) is the sole etiological treatment capable of modifying the natural progression of allergic diseases.
- Development of general vaccine modifications applicable across various allergens.
- Introduction of specific modifications for vaccines targeting house dust mites, animal allergens (horse, cat), parvalbumin, and pollens (birch, ragweed, parietaria).
Conclusions:
- Recent innovations in SIT have led to improved vaccine strategies for diverse allergic conditions.
- Ongoing research and patent activity indicate a dynamic field focused on enhancing the efficacy and applicability of allergy immunotherapy.
Related Concept Videos
Tumor Immunotherapy
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

